Stockreport

BridgeBio's US$550 Million Notes Offering and ATTR-CM Push Could Be A Game Changer For BBIO [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF investors on advancing late-stage programs and commercial traction for its ATTR-CM therapy Attruby and other pipeline assets. These financing and pipeline developments [Read more]